Genelux Corp (GNLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNLX | SLS | GNTA | ||
| Company | Genelux Corp | Sellas Life Sciences Group Inc | Genenta Science S.P.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.56 | 1.2500 | 4.96 | ||
| High | 2.56 | 1.2550 | 5.00 | ||
| Low | 2.34 | 1.1600 | 4.60 | ||
| Last | 2.46 | 1.2200 | 4.80 | ||
| Change | -0.03 | -0.0200 | +0.10 | ||
| % Change | -1.20% | -1.61% | +2.13% | ||
| Volume | 164,700 | 801,900 | 5,600 | ||
| 20-Day Average Volume | 179,595 | 822,540 | 7,385 | ||
| Previous Close | 2.49 | 1.2400 | 4.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.87 | 1.2320 | 5.02 | ||
| 20-Day Raw Stochastic | 11.10% | 41.38% | 33.96% | ||
| 20-Day Relative Strength | 44.93% | 48.80% | 48.48% | ||
| Weighted Alpha | -74.65 | +24.16 | -19.39 | ||
| Today's Opinion | 16% Sell | 24% Sell | 64% Buy | ||
| Previous Opinion | 16% Sell | 24% Buy | 64% Buy | ||
| Last Month's Opinion | 8% Sell | 40% Sell | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.33% since 11/14/24 | -3.94% since 11/14/24 | -1.84% since 11/14/24 | ||
| Low | 2.33 on 11/15/24 | 1.1600 on 11/21/24 | 4.44 on 11/20/24 | ||
| High | 2.94 on 11/15/24 | 1.3800 on 11/18/24 | 5.20 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -7.17% since 10/21/24 | +2.52% since 10/21/24 | -10.28% since 10/21/24 | ||
| Low | 2.33 on 11/15/24 | 1.0700 on 10/24/24 | 4.44 on 11/20/24 | ||
| High | 3.50 on 11/01/24 | 1.3900 on 11/13/24 | 5.64 on 10/22/24 | ||
| 3-Month | |||||
| %Chg | +20.00% since 08/21/24 | -6.87% since 08/21/24 | +17.07% since 08/21/24 | ||
| Low | 1.95 on 09/25/24 | 1.0700 on 10/24/24 | 3.30 on 09/19/24 | ||
| High | 3.60 on 10/16/24 | 1.3900 on 11/13/24 | 7.28 on 10/10/24 | ||
| 6-Month | |||||
| %Chg | -51.00% since 05/21/24 | -14.08% since 05/21/24 | +58.54% since 05/21/24 | ||
| Low | 1.60 on 08/05/24 | 0.8100 on 06/17/24 | 2.79 on 07/08/24 | ||
| High | 5.75 on 05/22/24 | 1.7000 on 06/14/24 | 7.28 on 10/10/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 86,000 | 87,274 | 85,963 | ||
| Shares Outstanding, K | 34,538 | 70,382 | 18,290 | ||
| Annual Sales | 170,000 | 0 | 0 | ||
| Annual Net Income | -28,300,000 | -37,340,000 | -12,600,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -6,580,000 | -7,110,000 | N/A | ||
| 60-Month Beta | -1.85 | 2.39 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/14/24 | -0.10 on 11/13/24 | N/A | ||
| Latest Earnings Date | 11/12/24 | 11/14/24 | 04/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||